CompletedNCT03089983
Daily Isoniazid or Weekly Isoniazid-Rifapentine for TB Prevention in Prisoners
About this title
Read the official source —Medication studyAges 18+MalaysiaAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- KajangSee all locations and recruitment
Study information
Study start dateStarted: August 21, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 316
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Malaysia
- Age range
- Over 18 Years
- Official registry ID
- NCT03089983
- Official title
Show the full official title
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
Get this study by email
Recruitment & locations
CompletedKajang
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including Isoniazid and Rifapentine.
Who was this study for?
Listed age limits: from 18 years.
Want to explore more studies?
Explore studiesRelated studies
A Qualitative Study of the Efficacy of Physical Activity Consultation as an Adjunct to Standard Smoking Cessation Treatment in the Context of Malaysia
Effectiveness of quit smoking motivation with carbon monoxide feedback module (COQUIT) among college smoker in Selangor